Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry is a novel long non-coding RNA (lncRNA) transcript located within an intron of the GMPS gene, on the sense strand. It is annotated in Ensembl and GeneCards as a non-coding RNA locus, with no described protein product, disease associations, or therapeutic interactions. Its biological function is unknown; there is no evidence it serves as a biomarker, mechanism of action, or safety concern. The naming is generic and likely refers to a transcript discovered through high-throughput sequencing annotation without additional functional characterization. No common abbreviation, structured molecule name, or aliases are assigned, and this transcript is not considered a canonical or actionable drug target[1][3][7]. In summary, ENSG00000288032 is an unnamed, uncharacterized lncRNA transcript (not a receptor, enzyme, transporter, or canonical drug target), with no known aliases, molecular function, disease role, or therapeutic interaction. The entry appears incomplete and not suitable for structure-based therapeutic evaluation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, sense intronic to GMPS (ENSG00000288032).